Advent Hotels (ADVENTHTL)

Cyclical

FairStock Score: 8/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Current Price₹141.58
Market Cap₹763.72 Cr
P/E Ratio12.09
ROCE3.28%
ROE—%
Dividend Yield0%
Profit Growth-79.8%
Debt/Equity0.78
Sales Growth0%
Promoter Holding47.69%
52-Week Range₹118.1 — ₹345.05
SectorLeisure Services
Book Value₹4,35,672.3

Strengths

Concerns

AI Analysis

At first glance, Advent Hotels looks like a classic value trap wearing a growth disguise. The stock trades at ₹159.80, near the low of its ₹118.10–₹345.05 52-week range, with a market cap of ₹1,046 Cr. A trailing P/E of 35.68 is not cheap for a company whose sales are growing only 4.02%. The reported ROCE of 3.28% also tells me the hotel assets are generating little return on capital, which is dangerous in a capital-intensive and cyclical industry. Profit growth of 175.27% sounds wonderful, but I always ask: from what base? The latest quarter shows sales of ₹115 Cr and net profit of ₹30 Cr. That single quarter’s profit roughly equals the entire trailing earnings implied by the P/E—around ₹29 Cr. Either the business has inflected sharply, or the trailing figures are distorted by a weak past. I need evidence, not hope. The Piotroski F-Score of 7/9 is genuinely encouraging; it suggests a healthier balance sheet and better cash conversion than last year. Promoter holding of 47.69% gives moderate confidence that insiders share my interest. But I cannot ignore missing data: ROE and debt/equity are unavailable, and the stated book value of ₹435,672.30 is absurd next to a ₹159.80 share price. I therefore treat P/B as meaningless. With no dividend, shareholders depend entirely on the cycle delivering higher earnings. A hotel business earning 3.28% ROCE must be bought at a deeply discounted price to compensate for cyclical volatility. At 35 times trailing earnings, there is no margin of safety. This is a cyclical/turnaround situation, not a predictable compounder. In Graham’s words, the investor’s chief problem is himself. I refuse to pay for a recovery that is not yet proven.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer